## GS: The Goldman Sachs Group, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.29 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-3.2% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($847.09)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Form 424B2 GOLDMAN SACHS GROUP INC**
- Source: StreetInsider | 20251230T180840 | Neutral | Relevance: 100%
- Goldman Sachs Group Inc. has filed Form 424B2 for Contingent Income Auto-Callable Securities linked to Micron Technology, Inc. stock, due December 29, 2028. These securities offer quarterly contingent coupons if Micron's stock price meets certain thresholds but carry principal at risk if the final share price falls below a downside threshold. The filing details the terms, risks, and tax considerations for investors, including automatic calls and potential loss of investment.

**2. Goldman Sachs stock slips as year-end volumes thin and Fed minutes loom**
- Source: ts2.tech | 20251230T170748 | Somewhat-Bearish | Relevance: 100%
- Goldman Sachs shares experienced a 0.9% drop to $883.73 in late morning trading due to thin year-end volumes and anticipation of Federal Reserve meeting minutes. This dip reflects a broader financial sector weakness as traders position themselves for the Fed's future rate signals. Investors are also looking ahead to Goldman's Q4 results on January 15 for insights into investment banking fees, trading revenue, and expense discipline.

**3. Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC**
- Source: StreetInsider | 20251230T160805 | Neutral | Relevance: 100%
- Goldman Sachs Group Inc. (GS) has filed Form FWP regarding "Market Linked Securities—Auto-Callable with Leveraged Upside Participation and Contingent Downside Principal at Risk Securities" linked to the SPDR Gold Trust and iShares Silver Trust, due February 2, 2029. The securities offer a potential call premium of at least 37% of the face amount and have a leveraged upside participation rate of 150%, but investors face downside exposure if the lowest performing underlier falls below its threshold price. The filing includes detailed terms, payment mechanisms, and an extensive list of associated risk factors for potential investors.

**4. Form 424B2 GOLDMAN SACHS GROUP INC**
- Source: StreetInsider | 20251230T090819 | Neutral | Relevance: 100%
- This SEC filing details a preliminary pricing supplement for Basket-Linked Notes due in 2029, issued by GS Finance Corp. and guaranteed by The Goldman Sachs Group, Inc. The notes' return is linked to the performance of a weighted basket of TOPIX, S&P 500®, and EURO STOXX 50® indices, with a potential for capital loss. The document outlines the calculation methodology, hypothetical examples of returns, and significant risks, including credit risk and foreign securities market exposure.

**5. Goldman Sachs stock drops after hours as year-end pullback hits banks — what investors watch next**
- Source: ts2.tech | 20251229T235023 | Somewhat-Bearish | Relevance: 100%
- Goldman Sachs stock, along with other major banks like JPMorgan Chase and Morgan Stanley, experienced a decline in after-hours trading as a year-end pullback impacted the market. The softer tape in trading occurred as Treasury yields eased, and investors focused on funding markets and the Fed’s standing repo facility. Investors are now watching for stabilization in yields and the impact on financial shares, especially with Goldman Sachs's fourth-quarter 2025 results scheduled for January 15, 2026.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Keefe, Bruyette | $971 | $870 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Keefe, Bruyette | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 6 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (-1.5%)
- Blackrock Inc.: 7.7% (+0.1%)
- State Street Corpora: 6.4% (-1.5%)
- JPMORGAN CHASE & CO: 4.7% (+99.2%)
- Morgan Stanley: 2.6% (-7.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.2% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.29 suggests fair value with growth premium. Quality metrics strong (margin 29%). Balance sheet: $2.1B free cash flow. Analyst sentiment positive (1 raises, avg +12%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $267.7B |
| Beta | 1.35 |
| 52W Range | $439.38 - $919.10 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.29 |
| Forward P/E | 16.0 |
| Current P/E | 18.1 |
| YoY Growth | 13.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 3.6% to 0.5% (-3.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.5pp (needs >4.0% for momentum thesis). MRS_5 (-1.2%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.04), momentum weakening. RSI neutral at 57. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.46% (CS: 55) | Neutral |
| RSI_14 | 57.4 | Neutral |
| MACD Histogram | -2.04 | Bearish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.072x | Above |
| vs SMA200 | 1.255x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $884.29
- **Stop Loss:** $847.09 (4.2% risk)
- **Target:** $958.69 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 22
- **Position Value:** $19,454.38
- **Portfolio %:** 19.45%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-15 (Est: $11.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $11.09 | $12.25 | +10.5% |
| 2025Q2 | $9.66 | $10.91 | +12.9% |
| 2025Q1 | $12.26 | $14.12 | +15.2% |
| 2024Q4 | $8.35 | $11.95 | +43.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*